Patents by Inventor Kayla BUSBY

Kayla BUSBY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240175010
    Abstract: Disclosed herein is a modified transposon end sequence comprising a mosaic end sequence, wherein the mosaic end sequence comprises one or more mutation as compared to a wild-type mosaic end sequence, wherein the mutation comprises a substitution with a uracil, an inosine, a ribose, an 8-oxoguanine, a thymine glycol, a modified purine, or a modified pyrimidine. Also disclosed are transposome complexes comprising these modified transposon end sequences and methods of library preparation using these modified transposon end sequences.
    Type: Application
    Filed: September 28, 2023
    Publication date: May 30, 2024
    Applicant: Illumina, Inc.
    Inventors: Allison Yunghans, Angelica Marie Barr Schalembier, Kayla Busby, Stephen M. Gross
  • Publication number: 20240150753
    Abstract: Described herein are compositions and methods for preparing double-stranded complementary DNA (cDNA) from RNA. In some embodiments, these methods allow isothermal preparation of cDNA. In some embodiments, these methods allow mesophilic or thermostable preparation of cDNA. Also described herein are compositions and methods for preparing cDNA and a library of double-stranded cDNA fragments in a single reaction vessel.
    Type: Application
    Filed: September 27, 2023
    Publication date: May 9, 2024
    Applicant: Illumina, Inc.
    Inventors: Allison Yunghans, Angelica Marie Barr Schalembier, Kayla Busby, Stephen M. Gross, Robert Scott Kuersten, Frederick W. Hyde
  • Publication number: 20240124921
    Abstract: Detecting analytes using proximity-induced tagmentation, strand invasion, restriction, or ligation is provided herein. In some examples, detecting an analyte includes coupling a donor recognition probe to a first portion of the analyte. The donor recognition probe includes a first recognition element specific to the first portion of the analyte, a first oligonucleotide corresponding to the first portion, and a transposase coupled to the first recognition element and the first oligonucleotide. An acceptor recognition probe is coupled to a second portion of the analyte. The acceptor recognition probe includes a second recognition element specific to the second portion of the analyte and a second oligonucleotide coupled to the second recognition element and corresponding to the second portion. The transposase is used to generate a reporter polynucleotide including the first and second oligonucleotides. The analyte is detected based on the reporter including comprising the first and second oligonucleotides.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 18, 2024
    Inventors: Andrew KENNEDY, Sarah SHULTZABERGER, Kayla BUSBY, Colin BROWN, Andrew PRICE, Eric VERMAAS, Rigoberto PANTOJA, Matthew Feeley, Jennifer ZOU, Yong LI, Sepideh ALMASI, Anindita DUTTA, Michelle ALVAREZ